Gemstone BioTherapeutics, LLC

Biotechnology company · Baltimore, Maryland, United States

Gemstone BioTherapeutics, LLC is a biotechnology company headquartered in Baltimore, Maryland, United States. Its earliest recorded incorporation is in 2013. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $224,867 in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $700,000 sold in a notice filed in 2016.

Profile compiled from public records. Is this your company? Request a correction or update

Gemstone BioTherapeutics at a glance

Typebiotechnology company
HeadquartersBaltimore, Maryland, United States
Earliest incorporation on record2013
Employees (self-reported, 2018)4
SEC CIK1644667

What does Gemstone BioTherapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $224,867 in total (2018). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $700,000 sold (2016).

Frequently asked questions about Gemstone BioTherapeutics

Where is Gemstone BioTherapeutics headquartered?

Gemstone BioTherapeutics, LLC is headquartered in Baltimore, Maryland, United States.

What does Gemstone BioTherapeutics do?

Gemstone BioTherapeutics, LLC is a biotechnology company.

When was Gemstone BioTherapeutics founded?

The earliest incorporation on record for Gemstone BioTherapeutics, LLC is in 2013, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences